DC Biosciences Limited

Home - DC Biosciences Pioneers in Proteomics

- DC Biosciences provides pharmaceutical and biotechnology companies with proteomic services to accelerate the development of safer drugs. Contact our experts.

CRN

SC303525

Founded

2006

Age

Overview

Browse spinouts

Legal name

DC BIOSCIENCES LIMITED

Region

Scotland

Registered address

Unknown

Insolvency history

Company events

Reference milestones and recent Companies House filing stream events.

1 event

07 Jun

2006

Incorporated

Inception

Company registered at Companies House

Spinout profile

1 entry

Company description

Dundee Cell Products (DCP) is a spin out company of University of Dundee of which Angus I Lamond is a co-founder. http://www.dundeecellproducts.com/ ; http://www.dundeecellproducts.com

Project impact

1. Dundee Cell Products has successfully commercialised SILAC quantitative proteomics technology to academic and commercial customers. It has carried out SILAC analysis for customers in about six universities and recently gained a service contract with one of the world's largest pharmaceutical companies to apply this technology in their drug discovery and development process. The company has also developed various SILAC ready-to-use tissue culture media that facilitate the culture of cell lines for subsequent quantitative proteomics analysis. These special SILAC media have gained customers all over Europe and in North America. 2. Since spinout, the company has commercialised life sciences research reagents including antibodies, recombinant proteins, DNA clones, stable cell lines, etc., many of which have been developed or licensed from Universities/academic institutions. 3. The company has created new jobs by employing five highly skilled staff (3 post-doctoral, two undergraduates). It also provides part-time work to two contractors (bookkeeper and accountant), work to local businesses and outsources some work to the University of Dundee thus providing extra revenue to the institution.

Dundee Cell Products

2006

http://www.dundeecellproducts.com/

Public funding

2 awards

First funded

2010

Funded years

2010, 2016

Age at first award

4 years

Projects

2016 Feasibility Studies

Opening the highway from genome sequencing to antibiotic discovery

1 Apr 2016 to 30 Sep 2017

Awarded

£31,437

Total cost £44,910

New antibiotics are urgently needed to replace those that are lost to increasing antibiotic resistance. Ourtechniques focus on using Synthetic Biology to transfer the biosynthetic gene clusters for antibiotics frompoorly- and un-characterised environmental species into optimised SuperHosts. Traditional approaches for thisfocus on constructing bacterial or...

2010 Knowledge Transfer Partnership

University of Dundee And Dundee Cell Products Limited

1 Jul 2010 to 31 Jan 2013

Awarded

Unknown

To establish the skills and expertise to provide Quantitative Proteomics services.

Product types

Feasibility Studies Knowledge Transfer Partnership